Table 2.
Family | OTU type |
Metabotype |
||
---|---|---|---|---|
1 | 2 | 1 | 2 | |
BSD2205 | 2 | 0 | 2 | 0 |
BSD2780 | 1 | 0 | 1 | 0 |
BSD3178 | 2 | 1 | 1 | 2 |
BSD3205 | 2 | 0 | 0 | 2 |
BSD3448 | 0 | 3 | 0 | 3 |
BSD3486 | 2 | 0 | 2 | 0 |
BSD3590 | 2 | 0 | 1 | 1 |
BSD3724 | 3 | 0 | 3 | 0 |
BSD3803 | 2 | 0 | 1 | 1 |
BSD3888 | 3 | 0 | 3 | 0 |
BSD3905 | 3 | 0 | 2 | 1 |
BSD4031 | 1 | 1 | 2 | 0 |
BSD4241 | 4 | 0 | 2 | 2 |
BSD4257 | 1 | 2 | 1 | 2 |
BSD4287 | 2 | 0 | 1 | 1 |
BSD4343 | 2 | 1 | 3 | 0 |
BSD4346 | 2 | 0 | 2 | 0 |
BSD4352 | 2 | 0 | 2 | 0 |
BSD4362 | 4 | 1 | 5 | 0 |
BSD5304 | 1 | 1 | 1 | 1 |
BSD5502 | 3 | 0 | 3 | 0 |
Total | 44 | 10 | 38 | 16 |
P value | .08 | .03 |
NOTE. Contingency tables are shown for OTU type and metabotype of the 54 non-IBD individuals across the 21 families in this cohort. P values were calculated using the Fisher exact test. Two families are highlighted (BSD4257, BSD3448) that contain at least 2 individuals with the IBD-associated OTU type and metabotype.